Frontlight ResearchEarly access
Trial site
Birmingham
- 9running trials
- 5closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease3 trials
- Stroke3 trials
- Follicular lymphoma2 trials
- Chronic spontaneous urticaria1 trial
- Diffuse large B-cell lymphoma1 trial
- Epilepsy1 trial
- Familial hypercholesterolaemia1 trial
- Hodgkin lymphoma1 trial
- Huntington's disease1 trial
- Immune thrombocytopenia (ITP)1 trial
- Lung cancer1 trial
- Myasthenia gravis1 trial
- and 3 more
- Phase
- Phase 39 trials
- Phase 23 trials
- Phase 11 trial
- Status
- Active, not recruiting9 trials
- Completed5 trials
- Lead sponsor
- Novartis Pharmaceuticals13 trials
- Advanced Accelerator Applications1 trial
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Closed trials
Completed
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome
Completed
Completed
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026